A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease

Clinical trial NCT03761849 · COMPLETED

Trial details

NCT number: NCT03761849
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Huntingtons Disease

Start date: 2019-01-23
Primary completion: 2022-03-24
Enrollment: 899

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.